Toll-like receptor 9 agonists up-regulates the expression of cyclooxygenase-2 via activation of NF-κB in prostate cancer cells
- 19 July 2009
- journal article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 37 (4) , 1849-1855
Abstract
CpG-oligonucleotides (CpG-ODNs), mimicking bacterial DNA, have recently been shown to stimulate prostate cancer invasion in vitro via Toll-like receptor 9 (TLR9). Since cyclooxygenase 2 (COX-2), frequently overexpressed in multiple tumor types including prostate cancer, is a causal factor for tumor development, invasion and metastasis, an interesting question is raised whether TLR9 regulates COX-2 expression in prostate cancer cells. To address this question, herein we examined COX-2 expression in PC-3 cells stimulated with different doses and time courses of CpG-ODNs. The regulatory role of NF-κB in TLR9-mediated COX-2 expression was also investigated. CpG-ODN was found to up-regulate the expression of COX-2 in PC-3 cells in a dose- and time-dependent manner, but have little impact on COX-1 expression. Moreover, CpG-ODN also promoted nuclear translocation and activation of NF-κB, which appeared to be required for COX-2 induction by CpG-ODN. Overall, TLR9 up-regulates COX-2 expression in prostate cancer cells, at least partially through the activation of NF-κB, which may be implicated in tumor invasion and metastasis.Keywords
This publication has 36 references indexed in Scilit:
- Cyclooxygenase‐2/carbonic anhydrase‐IX up‐regulation promotes invasive potential and hypoxia survival in colorectal cancer cellsJournal of Cellular and Molecular Medicine, 2009
- Forced COX-2 expression induces PGE2 and invasion in immortalized urothelial cellsUrologic Oncology: Seminars and Original Investigations, 2008
- Prostaglandin E2 Regulates Tumor Angiogenesis in Prostate CancerCancer Research, 2008
- NF-κB and cancer — identifying targets and mechanismsCurrent Opinion in Genetics & Development, 2008
- Many faces of NF-κB signaling induced by genotoxic stressJournal of Molecular Medicine, 2007
- Toll like receptor‐9 agonists stimulate prostate cancer invasion in vitroThe Prostate, 2007
- PC-SPES down-regulates COX-2 via inhibition of NF-κB and C/EBPβ in non-small cell lung cancer cellsInternational Journal of Oncology, 2006
- Toll-like receptors and innate antiviral responsesCurrent Opinion in Immunology, 2003
- Recognition of pathogen-associated molecular patterns by TLR familyImmunology Letters, 2003
- Human Keratinocytes Express Functional CD14 and Toll-Like Receptor 4Journal of Investigative Dermatology, 2002